MENU
VRDN
AS OF
Dec 24 closing price
Price
$32.28
Change
+$0.17 (+0.53%)
Capitalization
3.08B
70 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
VRDN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Viridian Therapeutics (VRDN) Ownership - Who owns Viridian Therapeutics?

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.08B
P/E Ratio
N/A
Total Cash
490.9M
Projected Growth
N/A
Total Debt
21.62M
Revenue
70.79M
Risk (Beta)
1.81
Dividend Yield
N/A
Total Cash/Share
5.14
Total Debt/Equity
N/A
Revenue/Share
0.87 USD as % of share price

Fundamentals

VRDN
Capitalization
3.08B
P/E Ratio
N/A
Risk (Beta)
1.81
Dividend Yield
N/A
Total Cash
491M
Total Cash/Share
5.14
Total Debt
21.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.87%
Revenue
70.8M
ROE
N/A
Book Value
314M
P/B Ratio
9.81
Cash Flow
N/A
Earnings
-3.03
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
822K
Current Ratio
11.28
Current Revenue Per Employee
493496.50
Dividends Per Share - Security
N/A
EBITDA
-298.48M
Float
N/A
Float - Current
N/A
Gross Income Margin
8.47
Revenue To Assets
-45.47
Shares Held By Institutions
3.03B
Shares Outstanding - Current
95.4M
Total Liabilities
74.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
68.388
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
VRDN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VRDN showed earnings on November 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading for VRDN
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com